Dr. William Fearon, Dr. Ajay Kirtane and Dr. C. Michael Gibson Discuss: A Large-Scale, Global Randomized Trial of Coronary Physiology Derived From Conventional Angiography Compared With An Invasive Pressure Wire-Based Approach to Guide Percutaneous Coronary Intervention March 29, 2026 Disclosures TBD
Dr. Divaka Perera and Dr. C. Michael Gibson Discuss: Controlled Trial of High-Risk Coronary Intervention With Percutaneous Left Ventricular Unloading (CHIP-BCIS3) March 29, 2026 Disclosures TBD
Dr. Stephen Juraschek and Dr. C. Michael Gibson Discuss: DASH-Patterned Groceries to Reduce Blood Pressure Among Adults With Treated Hypertension: Results From the GoFreshRx Randomized Clinical Trial March 28, 2026 Disclosures TBD
Dr. Byeong-Keuk Kim and Dr. C. Michael Gibson Discuss: Intensive Low-Density Lipoprotein Cholesterol Targeting in Patients With Atherosclerotic Cardiovascular Disease March 28, 2026 Disclosures: TBD
Dr. Luke Laffin and Dr. C. Michael Gibson Discuss: Kardinal: A Phase 2 Study of Tonlamarsen For the Treatment of Uncontrolled Hypertension March 28, 2026 Disclosures: TBD
Dr. Deepak Bhatt and Dr. C. Michael Gibson Discuss: Prevalence and Clinical Impact of Hypercortisolism in Individuals With Resistant Hypertension: Primary Results From the Momentum Study March 28, 2026 Disclosures: TBD
Dr. Lohendran Baskaran and Dr. C. Michael Gibson Discuss: Reliability of CAC=0 to Exclude Coronary Plaque in Diverse Global Cohorts: A Global Probability Study of Coronary Artery Disease (GPS-CAD) Analysis March 28, 2026 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Effects of Tirzepatide Compared With Dulaglutide on Expanded Cardiorenal Outcomes March 28, 2026 Disclosures TBD
Dr. Harmony Reynolds and Dr. C. Michael Gibson Discuss: Coronary Optical Coherence Tomography and Cardiac Magnetic Resonance Imaging to Determine Sex Differences in Underlying Causes of Myocardial Infarction With No Obstructive Coronary Arteries March 28, 2026 Disclosures: TBD
Dr. Pam Taub and Dr. C. Michael Gibson Discuss: Impact of Ivabradine on Orthostatic Intolerance, Quality of Life and Heart Rate in Post-Covid Postural Orthostatic Tachycardia Syndrome: Results From the Recover-Autonomic Trial March 28, 2026 Disclosures TBD
